Non-traditional lipid biomarkers in atherosclerotic cardiovascular disease: pathophysiological mechanisms and strategies to address residual risk
Atherosclerotic cardiovascular disease (ASCVD) pathogenesis is fundamentally driven by dyslipidemia, characterized by lipid metabolism disorders that facilitate cholesterol deposition within damaged vascular endothelia. This process culminates in atherosclerotic plaque formation and coronary stenosi...
Saved in:
| Main Authors: | Cong Wang, Haifeng Fu, Hao Xu, Handong Yang, Xinwen Min, Wenwen Wu, Zhixin Liu, Dongfeng Li, Yun Dong, Jun Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1576602/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel lipid profiles and atherosclerotic cardiovascular disease risk: insights from a latent profile analysis
by: Hongli Wan, et al.
Published: (2025-02-01) -
Probiotic membrane vesicles ameliorate atherosclerotic plaques by promoting lipid efflux and polarization of foamy macrophages
by: Boping Jing, et al.
Published: (2025-04-01) -
Assessing the applicability of protein residues in combination with lipid residues to reconstruct Indus foodways from Gujarat
by: Kalyan Sekhar Chakraborty, et al.
Published: (2024-12-01) -
Advancements in research to mitigate residual risk of atherosclerotic cardiovascular disease
by: Fan Shi, et al.
Published: (2025-08-01) -
Advanced Detection and Therapeutic Monitoring of Atherosclerotic Plaque Using CD36-Targeted Lipid Core Probe
by: Tingting Gao, et al.
Published: (2025-03-01)